Log in
Enquire now
‌

US Patent 11517532 Methods of treating hepatitis delta virus infection

Patent 11517532 was granted and assigned to Eiger BioPharmaceuticals on December, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Lonafarnib and ritonavir, or a pharmaceutically acceptable salt thereof, are used in combination to treat HDV infection. In one aspect, amorphous co-precipitates comprising lonafarnib, ritonavir, and a co-polymer are provided.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11517532 Methods of treating hepatitis delta virus infection

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.